Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Current Leases (2019 - 2025)

ENDRA Life Sciences has reported Current Leases over the past 3 years, most recently at $132330.0 for Q4 2021.

  • Quarterly Current Leases rose 73.03% to $132330.0 in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $132330.0 through Dec 2021, up 73.03% year-over-year, with the annual reading at $132330.0 for FY2021, 73.03% up from the prior year.
  • Current Leases was $132330.0 for Q4 2021 at ENDRA Life Sciences, up from $127696.0 in the prior quarter.
  • Over five years, Current Leases peaked at $132330.0 in Q4 2021 and troughed at $65295.0 in Q3 2019.
  • The 3-year median for Current Leases is $75052.0 (2020), against an average of $88367.8.
  • Year-over-year, Current Leases grew 12.76% in 2020 and then surged 73.44% in 2021.
  • A 3-year view of Current Leases shows it stood at $66193.0 in 2019, then rose by 15.54% to $76480.0 in 2020, then skyrocketed by 73.03% to $132330.0 in 2021.
  • Per Business Quant, the three most recent readings for NDRA's Current Leases are $132330.0 (Q4 2021), $127696.0 (Q3 2021), and $123192.0 (Q2 2021).